MYX 3.29% $4.40 mayne pharma group limited

Ann: Mayne Pharma announces sale of US retail generics business, page-34

  1. 1,367 Posts.
    lightbulb Created with Sketch. 256
    Hope CEO remuneration contract has plenty of generous incentives , provided there's a decent improvement in share value cant see too many Mayne shareholders begrudging CEO being very well rewarded for his efforts , as for former CEO surely he must have been looking after the right people to have survived as long as he did his remuneration was absurd for doing what ? decimating LT retail shareholders capital .
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.